Related Experiment Video
Updated: Aug 14, 2026

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
Catecholamine modulation of frontal cortical ignition during wakefulness, sleep and anesthesia
Bing Li1,2, Jia Zhao1, Yang Dan2
1Department of Anesthesiology, Songjiang Research Institute; Department of Emergency and Critical Disease, Songjiang Research Institute, Shanghai Key Laboratory of Emotions and Affective Disorders, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201600, China.
None:
Conscious awareness-diminished during non-rapid-eye-movement (NREM) sleep and general anesthesia-is prevalent during wakefulness, but the underlying mechanism remains poorly understood. Here, we show that activity of catecholamine neurons, known to be higher during wakefulness than NREM sleep, enhances cortical ignition, a process closely associated with conscious awareness. Chemogenetic activation and inactivation of catecholamine neurons, particularly dopaminergic neurons in the ventral tegmental area (VTA), respectively, increased and decreased the amplitude of anterior cingulate area (ACA) excitation evoked by visual cortex (V1) stimulation. Ketamine and isoflurane, two commonly used general anesthetics, greatly reduced V1-to-ACA activity propagation. In addition to suppressing ongoing cortical activity, these general anesthetics significantly reduced the activity of VTA dopaminergic and basal forebrain cholinergic neurons, with dopaminergic activity dropping well below its level during NREM sleep. The strong inhibition of frontal cortical activity evoked by V1 stimulation, prominent during NREM sleep, was also absent under ketamine and isoflurane anesthesia. These results indicate that general anesthesia and NREM sleep suppress global ignition through overlapping but non-identical mechanisms.
More Related Videos
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...